Hoey Investments’s Zomedica Corp. ZOM Stock Holding History

Hoey Investments’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-40	Closed	-$6	–	461
2024 Q3	$6	Hold	40	–	–	﹤0.01%	395
2024 Q2	$6	Buy	+40	New	+$6	﹤0.01%	395

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Hoey Investments's ZOM Position: Q4 2024 in Review

Hoey Investments sold out of Zomedica Corp. (ZOM) in Q4 2024, closing a stake of 40 shares — an estimated $6 sold.

Hoey Investments first reported a position in ZOM in Q2 2024 and held it in 2 quarters. The position peaked at $6 in Q3 2024. 93 funds tracked by Wall St. Rank hold ZOM as of Q4 2024.

Hoey Investments reported no remaining Zomedica Corp. position as of Q4 2024 after selling out during the quarter.
Hoey Investments sold 40 Zomedica Corp. shares in Q4 2024, an estimated $6.
Hoey Investments first reported a position in Zomedica Corp. in Q2 2024 and held it in 2 quarters.
Hoey Investments's Zomedica Corp. position peaked at $6 in Q3 2024.
93 funds tracked by Wall St. Rank held Zomedica Corp. as of Q4 2024.

Based on Hoey Investments's 13F filing for Q4 2024, filed 12 Feb 2025.